Brenus Pharma mis à l’honneur par BFM-TV

L’interview de Paul Bravetti est à suivre ici :

Stay tuned

BRENUS x MATWIN; Follow up project

Brenus’ therapeutic approach during AACR annual meeting 2022.

Efficacy results of our vaccine immunotherapy on a mCRC preclinical model

13 December 2021

2022 French delegation JP Morgan week